Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Aug;28(8):1421-8.
doi: 10.1161/ATVBAHA.108.167197. Epub 2008 May 1.

Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice

Affiliations

Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice

Edward Thorp et al. Arterioscler Thromb Vasc Biol. 2008 Aug.

Abstract

Objective: Atherosclerotic plaques that are prone to disruption and acute thrombotic vascular events are characterized by large necrotic cores. Necrotic cores result from the combination of macrophage apoptosis and defective phagocytic clearance (efferocytosis) of these apoptotic cells. We previously showed that macrophages with tyrosine kinase-defective Mertk receptor (Mertk(KD)) have a defect in phagocytic clearance of apoptotic macrophages in vitro. Herein we test the hypothesis that the Mertk(KD) mutation would result in increased accumulation of apoptotic cells and promote necrotic core expansion in a mouse model of advanced atherosclerosis.

Methods and results: Mertk(KD);Apoe(-/-) mice and control Apoe(-/-) mice were fed a Western-type diet for 10 or 16 weeks, and aortic root lesions were analyzed for apoptosis and plaque necrosis. We found that the plaques of the Mertk(KD);Apoe(-/-) mice had a significant increase in terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL)-positive apoptotic cells. Most importantly, there were more non-macrophage-associated apoptotic cells in the Mertk(KD) lesions, consistent with defective efferocytosis. The more advanced (16-week) Mertk(KD);Apoe(-/-) plaques were more necrotic, consistent with a progression from apoptotic cell accumulation to plaque necrosis in the setting of a defective efferocytosis receptor.

Conclusions: In a mouse model of advanced atherosclerosis, mutation of the phagocytic Mertk receptor promotes the accumulation of apoptotic cells and the formation of necrotic plaques. These data are consistent with the notion that a defect in an efferocytosis receptor can accelerate the progression of atherosclerosis and suggest a novel therapeutic target to prevent advanced plaque progression and its clinical consequences.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Total body weight and plasma lipoproteins of Apoe−/− and MertkKD;Apoe−/− mice
Body weight, total plasma cholesterol, and fast performance liquid chromatography gel-filtration profiles (from pooled plasma samples) from male Apoe−/− and MertkKD;Apoe−/− mice fed a Western-type diet for either (A) 10 wks or (B) 16 wks. n.s., statistically non-significant difference between the two groups of mice.
Figure 2
Figure 2. Mertk expression and aortic root lesion area in Apoe−/− and MertkKD; Apoe−/− mice after 10 wks and 16 wks on a Western-type diet
(A) Immunohistochemistry for Mertk and macrophages was performed as described in Materials and Methods. The isotype control IgG was matched for the anti-Mertk antibody. Sections were counterstained with hematoxylin. nec, necrotic area. (B) Aortic RNA from each genotype was subjected to RT-PCR for Mertk, as described in Materials and Methods. (C–D) Examples of hematoxylin and eosin-stained aortic root sections from each group of mice fed a Western-type diet for either (C) 10 wks or (D) 16 wks. Bar, 0.3 mm. Below each set of sections are graphs showing the quantified lesion area. n.s., statistically non-significant difference between the two groups of mice.
Figure 3
Figure 3. TUNEL-positive nuclei are increased in the aortic root lesions of MertkKD;Apoe−/− mice
TUNEL analysis of aortic root sections from Mertk+/+;Apoe−/− and Mertk−/−;Apoe−/− mice fed a Western-type diet for either (A) 10 wks or (B) 16 wks. Micrographs display nuclei (blue; Hoechst), TUNEL-positive signal (red), and merged images. Bar, 10 μm. Quantified data are shown below the images (* indicates P<0.05). (C) Similar to the images in (B), but the right image in each group shows merged nuclear, TUNEL, and macrophage (green) staining. Bar, 10 μm.
Figure 4
Figure 4. Plaque necrosis is increased in the aortic root lesions of MertkKD;Apoe−/− mice after 16 wks on a Western-type diet
The images show examples of sections of hematoxylin and eosin-stained aortic roots from each group of mice fed a Western-type diet for 16 wks. nec, necrotic areas. Bar, 100 μm. The graph shows quantification of necrotic areas (n = 10 per group; * indicates P<0.05).
Figure 5
Figure 5. Phagocytosis efficiency of apoptotic cells is decreased in MertkKD;Apoe−/− plaques
(A) Examples of nuclear (blue; Hoechst), TUNEL (red), and macrophage (green) staining to differentiate macrophage-associated (left column of images) from free (right column of images) apoptotic cells in aortic root lesions of 16-wk diet-fed Apoe−/− and MertkKD;Apoe−/− mice, respectively. (B) Examples of merged nuclear, TUNEL, and macrophage-stained images differentiating macrophage-associated (top image) from free (bottom image) apoptotic cells in aortic root lesions of Apoe−/− and MertkKD;Apoe−/− mice, respectively. Arrows indicate apoptotic bodies. (C) Quantitation of the free-to-macrophage-associated ratio of apoptotic cells in the lesions of the two groups of mice (* indicates P<0.05).

Comment in

References

    1. Virmani R, Burke AP, Kolodgie FD, Farb A. Vulnerable plaque: the pathology of unstable coronary lesions. J Interv Cardiol. 2002;15:439–446. - PubMed
    1. Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb Vasc Biol. 2005;25:2255–2264. - PubMed
    1. Schrijvers DM, De Meyer GR, Herman AG, Martinet W. Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability. Cardiovasc Res. 2007;73:470–480. - PubMed
    1. Vandivier RW, Henson PM, Douglas IS. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest. 2006;129:1673–1682. - PubMed
    1. Tabas I. Mouse models of apoptosis and efferocytosis. Curr Drug Targets. 2008 - PubMed

Publication types

MeSH terms